Clinical Trials Browser

NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT01799538 2026-05-01

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Phase 1/2 Recruiting

100 enrolled

Lymphangioleiomyomatosis

NCT03304678 2026-02-18

Discovery of Sirolimus Sensitive Biomarkers in Blood

Phase 2 Completed

33 enrolled 6 charts

Lymphangioleiomyomatosis

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Phase 1/2 Active not recruiting

7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT06889168 2026-01-21

LAMP-2

Phase 1 Recruiting

20 enrolled

Lymphangioleiomyomatosis

NCT03150914 2024-12-24

MILED

Phase 3 Active not recruiting

60 enrolled

Lymphangioleiomyomatosis

NCT01353209 2024-04-17

TRAIL

Phase 2 Completed

17 enrolled 13 charts

Lymphangioleiomyomatosis

NCT00414648 2023-11-02

MILES

Phase 3 Completed

89 enrolled 15 charts

Lymphangioleiomyomatosis

NCT03253913 2023-02-01

RESULT

Phase 2 Completed

25 enrolled 11 charts

Lymphangioleiomyomatosis

NCT03062943 2022-09-28

LAM

Phase 2 Completed

30 enrolled

Lymphangioleiomyomatosis

NCT05190627 2022-01-27

LORALAM

Phase 2 Unknown

62 enrolled

Lymphangioleiomyomatosis

NCT02484664 2022-01-20

COLA

Phase 2 Completed

12 enrolled 11 charts

Lymphangioleiomyomatosis

NCT05087134 2021-10-21

Characterizing LAM With 11C-Choline PET/CT

Phase EARLY_PHASE1 Unknown

50 enrolled

Lymphangioleiomyomatosis

NCT03525834 2021-09-09

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Phase 4 Completed

40 enrolled 10 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT04388371 2021-08-11

Glutamine PET Imaging in LAM

Phase 1 Completed

5 enrolled

Lymphangioleiomyomatosis

NCT04577937 2021-03-18

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Phase NA Unknown

15 enrolled

Sleep Apnea Syndromes, Sleep Wake Disorders, Lymphangioleiomyomatosis

NCT01059318 2020-11-19

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Phase 2 Completed

24 enrolled 13 charts

Lymphangioleiomyomatosis

NCT02061397 2020-08-25

SOS

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT03131999 2020-06-16

LAMP-1

Phase 1/2 Completed

18 enrolled 7 charts

Lymphangioleiomyomatosis

NCT01687179 2018-10-11

SAIL

Phase 1 Completed

14 enrolled 14 charts

Lymphangioleiomyomatosis

NCT02859194 2018-07-18

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

Phase NA Completed

10 enrolled

Bronchiectasis, Lymphangioleiomyomatosis, Pulmonary Disease, Chronic Obstructive, Acute Lung Injury, Familial Primary Pulmonary Hypertension

NCT00790400 2017-02-17

EXIST-2

Phase 3 Completed

118 enrolled 15 charts

CNS

Tuberous Sclerosis 2, Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Seizures, Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT02116712 2016-11-30